메뉴 건너뛰기




Volumn 33, Issue 24, 2015, Pages 2597-2599

"Right-to-try" legislation: Progress or peril?

Author keywords

[No Author keywords available]

Indexed keywords

COMPASSIONATE USE; DRUG INDUSTRY; DRUG THERAPY; ETHICS; FOOD AND DRUG ADMINISTRATION; HUMAN; LAW; LIFE EXPECTANCY; NOTE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICIAN; PRIORITY JOURNAL; TERMINALLY ILL PATIENT; TURNAROUND TIME; UNITED STATES; LEGISLATION AND JURISPRUDENCE; TERMINAL CARE;

EID: 84940502333     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.62.8057     Document Type: Note
Times cited : (17)

References (13)
  • 1
    • 84940554623 scopus 로고    scopus 로고
    • Updated June 25
    • Regulatory Affairs Professionals Society: 'Right-to-Try' Legislation Tracker. Updated June 25, 2015. www.raps.org/Regulatory-Focus/News/Databases/2015/05/01/21133/Right-to-Try-Legislation-Tracker/
    • (2015) 'Right-to-Try' Legislation Tracker
  • 2
    • 84902487175 scopus 로고    scopus 로고
    • Live or let die: Will the courts recognize in terminally ill patients a fundamental right to choose non-FDA approved drugs or does the FDA's stringent approval process carry sufficient merit?
    • Clayton RP: Live or let die: Will the courts recognize in terminally ill patients a fundamental right to choose non-FDA approved drugs or does the FDA's stringent approval process carry sufficient merit? Indiana Health Law Rev 5:123-153, 2008
    • (2008) Indiana Health Law Rev , vol.5 , pp. 123-153
    • Clayton, R.P.1
  • 3
    • 84940536716 scopus 로고    scopus 로고
    • Updated April 9
    • Health Affairs: Health Policy Brief: Right-to-Try Laws. Updated April 9, 2015. http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief-id=135
    • (2015) Health Policy Brief: Right-to-Try Laws
  • 5
    • 84940551816 scopus 로고    scopus 로고
    • U.S. Constitution, Article VI, Clause 2
    • U.S. Constitution, Article VI, Clause 2
  • 6
    • 70149104075 scopus 로고    scopus 로고
    • Expanded access to investigational drugs for treatment use. Final rule
    • US Food and Drug Administration, Health and Human Services: Expanded access to investigational drugs for treatment use. Final rule. Fed Regist 74:40900-40945, 2009
    • (2009) Fed Regist , vol.74 , pp. 40900-40945
    • US Food and Drug Administration1    Health and Human Services2
  • 7
    • 84920999925 scopus 로고    scopus 로고
    • Access to investigational drugs remains challenge despite new FDA rules
    • March 29
    • Hayes E: Access to investigational drugs remains challenge despite new FDA rules. Pink Sheet. Volume 31, March 29, 2010
    • (2010) Pink Sheet , vol.31
    • Hayes, E.1
  • 8
    • 70349928587 scopus 로고    scopus 로고
    • Expanded access rules pose quandary for drug developers
    • Mack GS: Expanded access rules pose quandary for drug developers. Nat Biotechnol 27:871-872, 2009
    • (2009) Nat Biotechnol , vol.27 , pp. 871-872
    • Mack, G.S.1
  • 9
    • 84940512933 scopus 로고    scopus 로고
    • False hope and toxic effects: Proposed changes to the FDA drug approval process would fail to benefit the terminally ill
    • Zacher A: False hope and toxic effects: Proposed changes to the FDA drug approval process would fail to benefit the terminally ill. Quinnipiac Health Law 14:251-283, 2011
    • (2011) Quinnipiac Health Law , vol.14 , pp. 251-283
    • Zacher, A.1
  • 10
    • 84920973014 scopus 로고    scopus 로고
    • Practical, legal, and ethical issues in expanded access to investigational drugs
    • Darrow JJ, Sarpatwari A, Avorn J, et al: Practical, legal, and ethical issues in expanded access to investigational drugs. N Engl J Med 372:279-286, 2015
    • (2015) N Engl J Med , vol.372 , pp. 279-286
    • Darrow, J.J.1    Sarpatwari, A.2    Avorn, J.3
  • 11
    • 80053352042 scopus 로고    scopus 로고
    • Translational research: 4 Ways to fix the clinical trial
    • Ledford H: Translational research: 4 ways to fix the clinical trial. Nature 477:526-528, 2011
    • (2011) Nature , vol.477 , pp. 526-528
    • Ledford, H.1
  • 12
    • 84929906921 scopus 로고    scopus 로고
    • Principles and challenges in access to experimental medicines
    • Rosenblatt M, Kuhlik B: Principles and challenges in access to experimental medicines. JAMA 313:2023-2024, 2015
    • (2015) JAMA , vol.313 , pp. 2023-2024
    • Rosenblatt, M.1    Kuhlik, B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.